ARTICLE | Top Story
FDA accepts Coulter's Bexxar BLA
November 14, 2000 8:00 AM UTC
The FDA accepted for filing CLTR's BLA for its Bexxar tositumomab radiolabeled anti- CD20 monoclonal antibody to treat relapsed or refractory low-grade or transformed low-grade B cell non-Hodgkin's ly...